Live Breaking News & Updates on சிறப்பு பார்மா நிறுவனம்
Stay updated with breaking news from சிறப்பு பார்மா நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PM360 Magazine Announces Winners of 2021 Trailblazer Awards prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
PM360 Magazine Announces Winners of 2021 Trailblazer Awards prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Investegate |PAION AG Announcements | PAION AG: PAION AG ANNOUNCES INITIATION OF PIVOTAL STUDY OF REMIMAZOLAM (BYFAVO(R)) IN PEDIATRIC PROCEDURAL SEDATION investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Investegate |PAION AG Announcements | PAION AG: PAION LAUNCHES GIAPREZA(R) (ANGIOTENSIN II) FOR THE TREATMENT OF REFRACTORY HYPOTENSION IN ADULTS WITH SEPTIC OR OTHER DISTRIBUTIVE SHOCK IN GERMANY investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
PAION ANNOUNCES PRODUCT LAUNCH OF BYFAVO (REMIMAZOLAM) IN SOUTH KOREA BY HANA PHARM DGAP-News: PAION AG / Key word(s): Market launch 07.04.2021 / 09:00 PAION ANNOUNCES PRODUCT LAUNCH OF BYFAVO TM (REMIMAZOLAM) IN SOUTH KOREA BY HANA PHARM Aachen (Germany), 07 April 2021 - The Specialty Pharma Company PAION AG (PA8; ISIN DE000A0B65S3; Frankfurt Stock Exchange Prime Standard) today announces that Hana Pharm, remimazolam licensee for South Korea, informed PAION about the launch of Byfavo TM (remimazolam) for the use in general anesthesia in South Korea. Remimazolam was approved in South Korea for general anesthesia in January 2021 and will be marketed under the brand name Byfavo ....